Sleep medicines in Canada: decisions beyond choosing a sleeping pill

Start with the sleep problem

Tell the clinician whether you have difficulty falling asleep, staying asleep, waking too early or remaining alert during the day. Include snoring, breathing concerns, pain, restless sensations, shift work, mood symptoms and medicines. A sleep medicine should not hide a problem that needs a different assessment.

Bring a brief sleep record and explain what you have tried. Ask whether cognitive behavioural therapy for insomnia is appropriate. CBT-I is a structured treatment, not simply a reminder to keep good habits. A medication discussion can be part of care without replacing this broader assessment.

Different medicine groups have different roles

Sleep-related prescribing may involve benzodiazepines, medicines often called Z-drugs, orexin-receptor antagonists or selected other medicines. Examples encountered in Canadian discussions include zopiclone, zolpidem, eszopiclone, lemborexant, suvorexant and daridorexant. The product, indication and current Canadian status should be checked individually.

Comparisons such as Belsomra versus Ambien or Lunesta versus Ambien should not be reduced to a general claim that one is best. Ask what outcome is being targeted, what evidence applies and which risks matter for you. A drug-family name is not a complete safety profile.

Brand names and foreign articles

US articles may discuss Ambien, Lunesta, Rozerem or Sonata alongside Canadian brand names. A matching record in a database does not establish current pharmacy stock, and a foreign brand may have no matching Canadian record. Use the ingredient and exact formulation when asking for advice.

Do not assume that a product sold under a familiar name has the same directions in every country. Check the Canadian patient information with a pharmacist. This is particularly important for sublingual, modified-release or other formulations that are not interchangeable with an ordinary tablet.

Sedating antidepressants and other off-label uses

Doxepin, trazodone, mirtazapine and other medicines may appear in sleep discussions. A medicine being sedating does not make it a universal insomnia treatment. Ask whether the proposed use is authorised or off-label, what evidence supports it and whether another condition is also being treated.

Similarly, gabapentin or a benzodiazepine prescribed for another reason should not be repurposed for sleep without advice. A medication list should reflect all prescribers and all intended uses. Adding a second medicine to counteract the first can create a more complicated problem if no one reviews the whole regimen.

Over-the-counter does not mean risk-free

Sedating antihistamines and combination “night-time” products can cause next-day effects and may duplicate ingredients in other products. Ask a pharmacist about the exact active ingredients, particularly if you take allergy, cold, pain or nausea medicines as well.

Choosing Wisely Canada highlights important concerns with sedating sleep products in older adults, including confusion and falls. Do not assume that a product is gentler because it is available without a prescription. Repeated sleep difficulty deserves assessment rather than indefinite self-treatment with a non-prescription sedative.

Next-day function and unusual behaviour

Ask about driving, work, falls and other tasks that require alertness. Record whether you feel groggy, confused, unsteady or unable to function as usual the next day. Follow the product's instructions about when and how it should be taken; do not improvise an extra dose during the night.

If you or another person notices unusual behaviour during sleep, a serious reaction or marked changes in awareness, seek prompt professional advice. For severe breathing difficulty, inability to wake normally or another emergency, call 911. A blog cannot determine whether a reaction is safe to watch at home.

Alcohol and other sedatives

Tell the prescriber and pharmacist about alcohol, cannabis, opioids, anxiety medicines and other sedating products. Do not assume that taking them at different times automatically removes interaction risk. Ask about the actual products and pattern of use.

If several clinicians are involved, make sure each has an up-to-date list. A medicine taken only occasionally still belongs on that list. Be accurate about how you use it; the purpose is to make the plan safe, not to judge you.

Duration, tolerance and stopping

Ask at the start how long the medicine is intended to be used and how it will be reviewed. If it stops helping, do not keep increasing the dose. A review should consider the sleep problem, other conditions, the product and adverse effects.

Regularly used sedatives may need an individual discontinuation plan. Do not copy a taper from an article or abruptly stop because you are worried about dependence. Contact your pharmacist or prescriber, especially if supply is running out. The plan should include what to do if symptoms change during reduction.

Prepare a focused sleep appointment

Bring your sleep record, medication list, actual product packages and the main daytime problem you want to improve. Ask what treatment is appropriate, what monitoring is needed and whether an examination or referral is required. Cost and access should be discussed before they cause a gap in care.

Care365's insomnia intake can help organise a non-emergency assessment conversation. It does not guarantee a sleeping medicine or establish access to every drug discussed here. Your next step may involve CBT-I, a medication review, investigation of another condition or a different care setting.

Common questions

Sources

• Choosing Wisely Canada: Insomnia and anxiety in older people
• Choosing Wisely Canada: Pharmacist recommendations
• NHLBI: Insomnia treatment
• Health Canada: Drug Product Database

Continue reading

• Sleep difficulties: routines, sleep inertia and preparing for assessment